Estée Lauder Partners with Serpin Pharma to advance your skin care innovation

Washington (DPA-AFX)-Estee Lauder (El) components, announced on Wednesday to be associated with the Serpin Pharma biotechnology company to explore using advanced anti-inflammatory research in skin care products.

Serpin Pharma’s own technology, based on serpine proteins, improves the body’s natural healing process to reduce inflammation, skin aging and sensitivity.

The collaboration supports the “Reimagated Beauty” strategy of Estee Lauder, who focuses on innovative, fast market solutions. The ongoing scientific studies aim to apply this technology to cosmetic products for visible improvements in skin health.

Currently, he traded to $ 74.27, up 0.45 percent or $ 0.34 on the New York Stock Exchange.